IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on August 12, 2014. The filing serves to announce the Company's financial results for the second quarter ended June 30, 2014.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely references the issuance of a press release containing the second-quarter results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 12, 2014) for actual revenue, net income, and earnings per share figures.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any forward-looking statements or guidance updates in the press release not captured in this 8-K summary.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial results.